期刊文献+

长期服用奥氮平对130例精神分裂症患者糖脂代谢及内分泌的影响 被引量:7

Effects of long-term administration of olanzapine on glycolipid metabolismand endocrine in 130 patients with schizophrenia
下载PDF
导出
摘要 目的:观察长期服用奥氮平对于精神分裂症患者糖脂代谢及内分泌的影响。方法:130例精神分裂症患者服用奥氮平6个月并于治疗前后测定空腹血糖(fasting plasma glucose,FPG)、总胆固醇(total cholesterol,TC)、甘油三酯(triglyceride,TG)、低密度脂蛋白胆固醇(low density lipoprotein cholesterol,LDL-C)、高密度脂蛋白胆固醇(high density lipoprotein cholesterol,HDL-C)、泌乳素(prolactin,PRL)、游离三碘甲状腺原氨酸(free triiodothyronine,FT3)与游离甲状腺素(free thyroxine,FT4)水平及体质指数(body mass index,BMI)。结果:治疗6个月后患者FPG、TC、TG、LDL-C、PRL、TEST、FT3、FT4水平较治疗前均有不同程度的改变,差异具有统计学意义(P<0.01)。结论:精神分裂症患者长期服用奥氮平对于糖脂代谢及内分泌水平将产生一定的影响。 Objective:To observe the e ffect of olanzapine on glycolipid metabolism and endocrine in patients with schizophrenia.Methods:Fasting plasma glucose(FPG),total cholesterol(TC),triglyceride(TG),low density lipoprotein cholesterol(LDL-C),high density lipoprotein cholesterol(HDL-C),prolactin(PRL),free triiodothyronine(FT3),free thyroxine(FT4)and body mass index(BMI)were determined in 130 patients with schizophrenia before and after treatment with olanzapine for 6 months.Results:The levels of FPG,TC,TG,LDL-C,PRL,TEST,FT3 and FT4 in patients after 6 months of treatment were different from those before treatment to a certain degree(P<0.01).Conclusion:Long-term administration of olanzapine in schizophrenic patients would have a certain effect on glucose metabolism and endocrine level.
作者 刘春龙 崔鹏 LIU Chunlong;CUI Peng(General Department,Tianjin Anding Hospital,Tianjin 300222,China)
出处 《上海医药》 CAS 2020年第5期40-42,共3页 Shanghai Medical & Pharmaceutical Journal
关键词 奥氮平 长期用药 精神分裂症 糖脂代谢 内分泌 olanzapine long-term medication schizophrenia glycolipid metabolism endocrine
  • 相关文献

二级参考文献68

  • 1沈渔郦.精神病学[M].5版.北京:人民卫生出版社,2009:503-504.
  • 2Newcomer JW. Metabolic considerations in the use of an-tipsychotic medications: a review of recent evidence[J]. J Clin Psychiatry,2007,68(Suppl 1):20-27.
  • 3Harvey PD,Pappadopulos E, Lombardo I, et al. Reduction of functional disability with atypical antipsychotic treatment:a randomized long term comparison of ziprasidone and haloperidol[J]. Schizophr Res, 2009,115 (1): 24-29.
  • 4Villari V, Rocca P, Fonzo V, et al. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation[J]. Prog Neuropsychopharmaeol Biol Psychiatry, 2008, 32 (2): 405-413.
  • 5Koro CE,Fedder DO,L'italien GJ ,et al. Assessment ot independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study[J]. BMJ, 2002,325 : 243-247.
  • 6Lindenmayer JP, Czobor P, Volavka J, et al. Changes in glucose and cholesterol levels in patients with schizophre- nia treated with typical or atypical antipsychitics[J]. Am J Psychiatry, 2003,160 (2): 290-296.
  • 7Simpson GM, Glick ID, Weiden PJ, et al. Randomized, controlled,double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in a- cutely ill inpatientswith schizophrenia or schizoaffective disorder[J]. Am J Psychiatry, 2011,161 (10) : 1837-1841.
  • 8De Herl M,Detraux J, Peuskens J. Second-generation and new-ly approved antipsychotics, serum prolactin levels and sexualdysfunctions: a critical literature review[J]. Expert Opin DrugSaf, 2014,13(5): 605-624.
  • 9Peuskens J, Pani L, Detraux J, et al. The effects of novel andnewly approved antipsychotics on serum prolactin levels: a com-prehensive review[J]. CNS Drugs, 2014,28(5): 421-453.
  • 10Marken PA, Haykal RF, Fisher JN. Management of psychotro-pic-induced hyperprolactinemia[J]. Clin Pharm, 1992,11(10):851-856.

共引文献116

同被引文献68

引证文献7

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部